The pediatric mask sector is projected to expand from US$ 734.04 million in 2023 to US$ 1,068.48 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.8% during the period from 2023 to 2031. This growth in the pediatric mask market is primarily driven by the rising incidence of respiratory illnesses among children, coupled with an increase in training initiatives for healthcare professionals.
Pediatric masks are specifically designed medical devices that provide oxygen to children suffering from respiratory conditions such as asthma and pneumonia. These masks play a crucial role in ensuring adequate oxygen levels in pediatric patients, thereby preventing complications associated with their medical conditions.
In 2023, North America held a significant portion of the global pediatric mask market. This market is divided into segments including the United States, Canada, and Mexico. The rise in respiratory diseases among children and heightened investments in medical technology are key factors expected to drive the growth of the pediatric mask market in North America throughout the forecast period.
The United States represents a substantial share of the pediatric mask market within North America. The market's expansion in the country is largely influenced by the increasing rates of asthma, pneumonia, and sleep apnea. Additionally, the demand for innovative pediatric masks aimed at enhancing treatment quality is boosting the market in the US. For example, the Centers for Disease Control and Prevention (CDC) reported that approximately 4.6 million children were diagnosed with asthma in 2021. Furthermore, the March of Dimes Organization noted that there were 380,548 preterm births in the US in 2022, accounting for 10.4% of all live births. Pediatric masks are not only essential for asthma management but are also critical for assisting preterm infants with their breathing needs. Thus, the rise in preterm births and the increasing prevalence of asthma among newborns are significant contributors to the demand for pediatric masks in the United States.
Several companies, including SunMed, ResMed, and Fisher & Paykel, are based in the US and are actively pursuing strategic initiatives to realize their objectives. For instance, in April 2024, Dynarex Corporation introduced a new range of portable products under its innovative respiratory therapy line, named Dynarex Resp-O2.
Increasing Demand for Single-Use Pediatric Masks Presents Future Market Opportunities
There has been notable progress in healthcare services and facilities worldwide, leading to a heightened demand for various medical products, particularly single-use devices. Single-use masks are increasingly favored globally due to growing concerns about patient safety, the reduction of healthcare-associated infections, and improved management of respiratory infectious diseases. These masks are pre-sterilized and ready for immediate use, significantly cutting down on the time required for cleaning and sterilization. They are particularly useful in treating patients with highly contagious illnesses, such as severe pneumonia and H1N1 influenza.
Moreover, the rising incidence of emergency situations, including asthma attacks, allergic reactions, and trauma, along with the increasing number of immunocompromised children susceptible to respiratory issues, is anticipated to create further growth opportunities in the pediatric mask market in the years ahead.
Pediatric Mask Market: Competitive Landscape and Recent Developments
Key players in the pediatric mask market include Koninklijke Philips NV, ResMed Inc, BLS Systems Limited, Besmed Health Business Corp, Flexicare (Group) Limited, Sleepnet Corporation, Circadiance, Dynarex Corp, Intersurgical Ltd, Armstrong Medical Ltd, Ambu AS, SunMed Group Holdings LLC (AirLife), Dragerwerk AG & Co KGaA, and Fisher & Paykel Healthcare Corp Ltd.
In preparing the pediatric mask market report, primary and secondary sources such as the US Food and Drug Administration, the American College of Allergy Asthma and Immunology, and The Barcelona Institute for Global Health were utilized.